GlassScriptPhysician profile
Angela Mccally
NPI 1740875855
$3,703.78
in general payments reported to CMS, 2019-2025
44 companies · $894 in 2025
The $894 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $971 · 2023: $938 · 2024: $714 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,545.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $833.33 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $544.12 | 2021-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $462.31 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $162.96 | 2022-2025 | Airsupra, Farxiga, Evusheld |
| Lilly USA, LLC | $143.50 | 2021-2024 | Jardiance, Emgality, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $120.25 | 2021-2024 | Xifaxan |
| Abbvie INC. | $109.97 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.59 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $77.54 | 2023-2025 | Rexulti |
| Corcept Therapeutics | $73.47 | 2025 | Korlym |
| Glaxosmithkline, LLC. | $68.82 | 2022-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $67.04 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Phathom Pharmaceuticals, INC. | $60.10 | 2024-2025 | Voquezna |
| Daiichi Sankyo INC. | $57.00 | 2022 | |
| Merck Sharp & Dohme LLC | $52.33 | 2021-2025 | Capvaxive, Gardasil 9, Vaxneuvance |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Mccally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.